FNC discusses enhancing parliamentary relations with Speaker of Senate of Burundi
May 13, 2023
MBABANE, 13th May, 2023 (WAM) — Dr. Adnan Hamad Al Hammadi, member of the Federal National Council (FNC), has met
May 2023
DEWA presents five research papers at International Conference on IT Innovations and Knowledge Discovery 2023, Bahrain
May 13, 2023
DUBAI, 13th May, 2023 (WAM) — Dubai Electricity and Water Authority (DEWA) has participated in the International Conference on IT
Sharjah Social Security Fund commits to providing decent life
May 13, 2023
SHARJAH, 13th May, 2023 (WAM) — The Sharjah Social Security Fund has confirmed its commitment to providing quality services that
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vertex Energy, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – VTNR
May 12, 2023
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
ROSEN, A LEADING LAW FIRM, Encourages Tupperware Brands Corporation Investors to Secure Counsel Before Important May 19 Deadline in Securities Class Action First Filed by the Firm – TUP
May 12, 2023
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
TSE INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Trinseo PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – TSE
May 12, 2023
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers
EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Icahn Enterprises L.P. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IEP
May 12, 2023
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
May 12, 2023
Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that